4 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Peter Salzmann
Dyne Therapeutics
3 followers
Alexion Pharmaceuticals
34 followers
Bio-Rad Laboratories
19 followers
REVOLUTION Medicines
5 followers
Prenetics
5 followers
Owkin
4 followers
Tessera Therapeutics
2 followers
Arcutis Biotherapeutics
2 followers
Amgen
196 followers
Entrada Therapeutics
1 follower
Fractyl
1 follower
Explore companies